Table 2.
The expressional profile of Wnt7a in endometrial carcinoma and its precursor lesions.
| Number | Wnt7a expression | P*-value | ||
|---|---|---|---|---|
| Negative (%) | Positive (%) | |||
| Proliferative endometrium | 12 | 2 (16.7) | 10 (83.3) | 0.004 |
| Secretory endometrium | 13 | 1 (7.7) | 12 (92.3) | <0.001 |
| Atrophic endometrium | 10 | 1 (10.0) | 9 (90.0) | 0.002 |
| Simple hyperplasia | 16 | 3 (18.8) | 13 (81.2) | 0.002 |
| Complex hyperplasia | 17 | 4 (23.5) | 13 (76.5) | 0.004 |
| Endometrial carcinoma | 70 | 44 (62.9) | 26 (37.1) | |
Proliferative endometrium versus carcinoma: 0.004; Secretory endometrium versus carcinoma: <0.001; Atrophic endometrium versus carcinoma: 0.002; Simple hyperplasia versus carcinoma: 0.002; Complex hyperplasia versus carcinoma: 0.004 and *Chi-square test.